The Association of FLT3-ITD Gene Mutation with Bone Marrow Blast Cell Count, CD34, Cyclin D1, Bcl-xL and hENT1 Expression in Acute Myeloid Leukemia Patients

سال انتشار: 1399
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 193

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJP-15-4_008

تاریخ نمایه سازی: 26 آذر 1399

چکیده مقاله:

Background & Objective:  FLT3-ITD has been recently used as a molecular prognostic marker for risk classification in acute myeloid leukemia (AML) therapy. In this study we aimed to investigate the association of FLT3-ITD gene mutation with bone marrow blast cell count, CD34 expression as malignant cell burden, cyclin D1 and Bcl-xL expressions as indexes of cell proliferation and anti-apoptosis and human equilibrative nucleoside transporter 1 (hENT1) expression as cytarabine transporter during AML treatment. Methods:  We investigated FLT3-ITD mutations, bone marrow blast cell count, CD34, cyclin D1, Bcl-xL and hENT1 expression in bone marrow aspirates from 22 de novo AML patients in a cross sectional study. Results:  FLT3-ITD mutations were observed in 5 out of 22 de novo AML patients (22.7%). Patient with FLT3-ITD mutations had higher blast cell counts (79.5% vs 56.1%, p =0.004). In patients with FLT3-ITD mutations, CD34 and cyclin D1 expressions were higher (MFI 328.80 vs 25.78, p =0.003 and MFI 74.51 vs 57.15 p =0.005) than the patients without mutations. hENT1 expression in AML with FLT3-ITD mutation was lower (MFI 29.64 versus 56.32, p =0.0000) than in mutation-free AML. There was no significant difference in Bcl-xL expression between patients with and without mutations (p =0.61). Conclusion:  A significant association was found between FLT3-ITD gene mutations in AML patients with bone marrow blast cell count, CD34, cyclin D1 and hENT1 expressions, however no association was obtained with Bcl-xL expression. These findings support the role of such mutation in pathogenesis of AMLand its contribution in rearrangement of standard therapy with cytarabine in management of AML.

کلیدواژه ها:

نویسندگان

Paulus Notopuro

Faculty of Medicine, Airlangga University, Jawa, Indonesia

Jusak Nugraha

Department of Clinical Pathology, Faculty of Medicine, Airlangga University, Jawa, Indonesia

Budi Utomo

Department of Public Health, Faculty of Medicine, Airlangga University, Jawa, Indonesia

Harianto Notopuro

۴. Department of Biochemistry and Molecular Biology, Faculty of Medicine, Airlangga University, Jawa, Indonesia

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Seer cancer statistic review (CSR) 1975 - 2014 [Internet]. National ...
  • Yohe S. Molecular genetic markers in acute myeloid leukemia. J ...
  • Ferrara F, Palmieri S, Leoni F. Clinically useful prognostic factors ...
  • Grafone T, Palmisano M, Nicci C, Storti S. An overview ...
  • Patnaik MM. The importance of FLT3 mutational analysis in acute ...
  • Schuurhuis GJ, Kedler A, Terwijn M, Rutten AP, Smit L, ...
  • Zhu HH, Liu Y-R, Jiang H, Lu J, Qin Y-Z, ...
  • Haferlach T, Bacher U, Alpermann T, Haferlach C, Kern W, ...
  • Catala A, Pastor-Anglada M, Caiedes-Cardenas L, Malatesta R, RIves S, ...
  • Jin G, Matsushita H, Asai S, Tsukamoto H, Ono R, ...
  • Gorczyca W, Emmons FN. Immunophenotyping. In: Gorczyca W, Emmons FN, ...
  • Licinio MA, Silva MCSd. Importance of detecting FLT3 and NPM1 ...
  • Sarojam S, VIjay S, Raveendran S, Sreedharan J, Narayanan G, ...
  • Rombouts E. Internal tandem duplications in the Flt3-gene in human ...
  • Notopuro PB, Notopuro H, Budiwijono I, Adhipireno P. The difference ...
  • Kumsaen P, Fucharoen G, Sirijerachai C, Chainansamit S-o, Wisanuyothin N, ...
  • Wang L, Xu Wl, Meng Ht, Qian Wb, Mai Wy, ...
  • Yunus NM, Johan MF, Al-Jamal HAN, Husin A, Hussein AR, ...
  • Thiede C, Steudel C, Mohr B, Schaich M, Schakel U, ...
  • Molica M, Breccia M. FLT3-ITD in acute promyelocytic leukemia: clinical ...
  • Alejandro F, Rangel L, Chavez-Valencia V. FLT3-ITD and its current ...
  • Aref S, Mabed M, El-Sherbiny M, Selim T, Metwaly A. ...
  • Pallis M, Zhu Y-M, Russell N. BCL-XL is heterogeneously expressed ...
  • Elyamany G, Awad M, Fadalla K, Albalawi M, Shahrani MA, ...
  • Ibrahim EK, Assem MM, Amin AI, Kamel M, Meligui YME, ...
  • Kottaridis PD, Gale RE, Frew ME, Harrison G, Langabeer SE, ...
  • Anglada MP, Torras SP. Nucleoside transporter proteins as biomarkers of ...
  • Chabner BA. Antimetabolites: fluoropyrimidines and other agents. In: Chabner BA, ...
  • Zhang J, Visser F, King KM, Baldwin SA, Young JD, ...
  • Safaie A, Monabati A, Mokhtari M, Safavi M, Solhjoo F. ...
  • Aleem E, Arceci RJ. Targetting cell cycle regulators in hematologic ...
  • Eltzshig HK, Abdulla P, Hoffman E, Hamilton KE, Daniels D, ...
  • Huang W, Zeng X, Shi Y, Liu M. Functional characterization ...
  • Mehrazma M, Rafsanjani KA, Torkamanipoor B. Correlation between soluble vascular ...
  • Wan H, Zhu J, Chen F, Huang H, Han X, ...
  • نمایش کامل مراجع